Medunik Canada obtains new Notice of Compliance from Health Canada for Ruzurgi® (amifampridine) following a favourable Canadian Federal Court of Appeal ruling  read more
A unique company

dedicated to improving the health and quality of life of Canadians with rare diseases by bringing orphan drugs to Canada

What is a rare disease?

An illness that affects a small percentage of the population, thereby limiting research, clinical expertise and patient access to effective treatment options

What is an orphan drug?

A medication or other medicinal product used to treat a rare disease or disorder

Medunik Canada: A Pharmaceutical Company with a Unique Mission

Medunik Canada is dedicated to providing Canadians suffering from rare diseases with access to orphan drugs that are not currently available in Canada. We make these treatment options available by building strategic partnerships with international companies to bring their products to the Canadian market.